Medical Science Liaison - Southeast

Relay Therapeutics; Brewster Heights (NY); Hybrid; USD 219,000 - 260,000; Full time

Job summary

Relay Therapeutics is seeking an experienced Medical Science Liaison (MSL) to transform the breast cancer treatment landscape through precision medicine. The field-based role focuses on engaging oncologists and researchers, supporting clinical trials, and delivering scientific education.

Travel up to 60% is expected, with base salary in the reported range. Ideal candidates hold an advanced clinical degree and 5+ years as an MSL in solid tumor oncology, with strong communication skills and

Qualifications

• Advanced clinical degree preferred (PharmD/PhD/MD).
• 5+ years in an MSL or field-based role, oncology focus.
• Deep understanding of oncology, clinical research, and biomarker testing.
• Strong presentation and communication skills, audience-tailored discussions.
• Willingness to travel up to 60%.

Responsibilities

• Engage with Key Opinion Leaders (KOLs) – build and maintain relationships with oncologists, researchers, and stakeholders to discuss breast cancer advances.
• Support Clinical Trials & Patient Recruitment – work with trial sites, investigators, and providers to facilitate enrollment and address site challenges.
• Provide Scientific & Medical Education – deliver presentations and lead discussions on breast cancer, biomarker testing, and Relay Tx programs at hospitals, centers, and conferences.
• Stay Ahead of the Science – keep up with emerging breast cancer treatments and precision medicine developments.
• Represent Relay Tx at Key Events – attend oncology conferences, advisory boards, and investigator meetings.
• Gather & Share Field Insights – collect feedback to inform Relay Tx’s clinical and medical strategies.
• Ensure Compliance & Ethical Exchange – adhere to regulations and company policies in all interactions.

Skills

KOL engagement

Clinical trials support

Scientific communication

Breast cancer knowledge

Travel readiness

Education

Advanced degree (PharmD, PhD, MD)

Job description

At Relay Therapeutics, we are on a mission to transform the treatment landscape for breast cancer through precision medicine. As a Medical Science Liaison (MSL), you’ll play a crucial role in bridging the gap between our science and the oncology community. In this field-based role, you’ll engage with oncologists, clinical researchers, and healthcare professionals to provide scientific insights, support clinical trials, and drive awareness of our investigational therapies.

If you’re committed to advancing breast cancer research and thrive on scientific exchange, we’d love to have you on our team!

Your Role

• Engage with Key Opinion Leaders (KOLs) – Build and maintain relationships with oncologists, researchers, and other key stakeholders in your region to exchange scientific insights and discuss the latest advances in breast cancer research.
• Support Clinical Trials & Patient Recruitment – Work closely with trial sites, investigators, and healthcare providers to facilitate patient enrollment, answer medical questions, and troubleshoot site-related challenges.
• Provide Scientific & Medical Education – Deliver presentations and lead discussions on breast cancer, biomarker testing, and Relay Tx’s clinical programs at hospitals, cancer centers, and conferences.
• Stay Ahead of the Science – Continually update your knowledge of emerging breast cancer treatments, competitive therapies, and the evolving landscape of precision medicine.
• Represent Relay Tx at Key Events – Attend and contribute to major oncology conferences, advisory boards, and investigator meetings.
• Gather & Share Field Insights – Capture feedback from healthcare professionals to help inform Relay Tx’s clinical and medical strategies.
• Ensure Compliance & Ethical Exchange – Adhere to industry regulations, company policies, and legal guidelines in all interactions.

Your Background

• Advanced degree preferred (PharmD, PhD, MD); other relevant clinical backgrounds (NP, PA, RPh) considered with significant experience.
• 5+ years in an MSL or similar field-based role, ideally in solid tumor oncology with a strong focus on breast cancer.
• Deep understanding of oncology, clinical research, and biomarker testing.
• Strong presentation and communication skills, with the ability to tailor scientific discussions to different audiences.
• Self-motivated and able to manage your schedule effectively in a field-based role.
• Comfortable traveling up to 60%, including overnight stays for site visits, conferences, and team meetings.

Estimated Salary Range: [ $219,000 - $260,000 ]

The range provided above is based on what we believe to be a reasonable estimate for this job at the time of posting. Actual base salary will depend on a number of factors, including but not limited to, a candidate’s education, experience, skills and location.

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, we aim to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our Dynamo platform integrates an array of leading-edge experimental and computational approaches to provide a differentiated understanding of protein structure and motion to drug these targets. We have built a world-class team of leading experts from each of these disciplines, and they are driven by a deep collaboration at every step of our drug discovery process.

Our team is equal partsfearlessandrelentless, with a shared passion for working collaboratively in intellectually stimulating environments. If you’re excited by the challenge of putting protein motion at the heart of drug discovery and passionate about making a difference in the lives of patients, join us!

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey.Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiringprocess or thereafter. Any information that you do provide will be recorded and maintained in aconfidential file.

As set forth in Relay Therapeutics’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection.As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measurethe effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categoriesis as follows:

A \"disabled veteran\" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A \"recently separated veteran\" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An \"active duty wartime or campaign badge veteran\" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An \"Armed forces service medal veteran\" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.